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To assess the frequency and degree of valvular regurgita- transplant recipients than in normal subjects (156 + 120 
tion in combined heart and lung transplant recipients, 50 and 84 f 52 mm* compared with 40 f 38 and 28 + 26 mm’, 
patients were investigated using Doppler color flow echo- respectively); pulmonary regurgitant jet area was not sig 
cardiography 20 to 909 days (mean 369) after heart-lung nificantly different in the two groups (32 f 26 and 28 + 26 
transplantation. The mean age (*SD) of the patients was 25 mm’, respectively). Regurgitant jet area was not signifi- 
+ 9 years. No patient had evidence of rejection at the time cantly correlated with patient or donor age, donor organ 
of the study. Fifty normal volunteers acted as control total ischemic time, time after operation, use of steroids for 
subjects. immunosuppression or total number of rejection episodes. 
Tricuspid, mitral and pulmonary regurgitation were 
commonly observed in the patients undergoing heart-lung 
transplantation (78%, 52% and 68%, respectively), but 
were not significantly more frequent than in the normal 
subjects (68%) 42% and 70%) respectively). Aortic regur- 
gitation was uncommon in both groups (4% and 2%, 
respectively). However, tricuspid and mitral regurgitant jet 
areas were significantly greater (p < 0.01) in heart-lung 
These results show that valvular regurgitation is not 
significantly more frequent after heart-lung transplantation 
than in normal subjects, but atrioventricular (AV) valve 
regurgitation, when present, is significantly greater in 
degree. This suggests that the degree but not the frequency 
of AV valve regurgitation is related to transplantation. 
(J Am Coil Cardiol1990;15:576-81) 
Varying degrees of atrioventricular (AV) valve regurgitation 
have been reported after orthotopic cardiac transplantation 
(l-3). The exact frequency, severity and causes of this 
abnormality are still unknown. The procedure of combined 
heart and lung transplantation differs from orthotopic car- 
diac transplantation in several respects, including the fact 
that the left atrium is transplanted intact (that is, it is not 
interfered with) and the newly transplanted lungs almost 
always have normal pulmonary vascular resistance (4,5). 
Valve function after heart-lung transplantation has not been 
studied before, and the purpose of this study was to assess 
the frequency and degree of valvular regurgitation after 
From the *Departments of Cardiac Surgery and Cardiology, Harefield 
Hospital, Harefield, Middlesex, England and tDepartment of Cardiology, 
Kobe General Hospital, Minatojima-nakamachi, Chuo-ku, Kobe, Japan. Dr. 
Lythall is funded as a Fellow by the British Heart Foundation, London, 
England. 
Manuscript received June 13, 1989; revised manuscript received October 
4, 1989, accepted October 18, 1989. 
Address for reorints: Magdi H. Yacoub, FRCS, Cardiac Surgical Unit, 
Harefield Hospital, Harefield, Middlesex UB9 6JH, England. 
heart-lung transplantation and to identify possible factors in 
its development. 
Methods 
Study patients. Fifty-three heart-lung transplant recipi- 
ents were studied by Doppler color flow echocardiography at 
the time of cardiac biopsy or annual follow-up study. All 
gave informed consent. Three patients were excluded be- 
cause of poor acoustic windows and inadequate echocardio- 
graphic images; therefore, 50 patients were suitable for 
analysis. Patient age ranged from 9 to 50 (25 t 9, mean ? 1 
SD) years. Donor age was 4 to 28 (17 +- 7) years. Time since 
operation was 20 to 909 days (mean 369). Indications for 
transplantation were primary pulmonary hypertension in 14 
patients, Eisenmenger’s syndrome in 21, cystic fibrosis in 9, 
alpha-l antitrypsin deficiency-associated emphysema in 2 
and fibrosing alveolitis, bronchoalveolar carcinoma, primary 
pulmonary hemosiderosis and pulmonary lymphangioleimo- 
matosis in 1 patient each. 
Transplantation was carried out by previously described 
techniques (6). Lung preservation was achieved by donor 
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Table 1. Echocardiographic Findings in 50 Heart-Lung Transplant Recipients and 50 
Norma1 Subiects 
M Mode and 2DE Findings 
LVDd LAD 
(mm) % FS (mm) 
Doppler Findings 
MR TR PR AR 
(%) (9) (%‘c) (%I 
TR 
Gradient 
(mm Hg) 
H-L transplant 
recipients 
Normal 
subjects 
43 t 5 32 + 7 29 + 5 52 78 68 4 19 f 4 
43 k 4 38 ? 6 30 + 3 42 68 70 2 18 + 4 
AR = aortic regurgitation; % FS = percent fractional shortening; H-L = heart and lung; LAD = left atrial 
dimension; LVDd = left ventricular end-diastolic dimension; MR = mitral regurgitation; PR = pulmonary 
regurgitation: TR = tricuspid regurgitation: 2DE = two-dimensional echocardiography. 
core cooling using cardiopulmonary bypass (7). Total isch- 
emit time ranged from 28 to 300 min (mean 174 -t 58). No 
subject had evidence of cardiac or pulmonary rejection on 
physical examination, chest X-ray film, lung function tests or 
endomyocardial biopsy at the time of echocardiography. All 
subjects were receiving cyclosporin A and azathioprine, and 
21 had taken steroids for >3 months. No patient had 
sustained hypertension. 
Fifty normal healthy volunteers (27 male and 23 female) 
matched for donor age (range 6 to 30 years; mean 17 2 7) 
acted as control subjects. 
Echocardiography. Examinations were performed with 
patients in the supine and left lateral decubitus position with 
use of a Toshiba SSH-65A scanner and a 2.5 MHz trans- 
ducer. It was possible to obtain comparable echocardio- 
graphic views and windows both in patients with a heart-lung 
transplant and normal subjects. Two-dimensional studies 
were recorded on videotape and analyzed for anatomy and 
wall motion. M-mode studies were recorded on videotape 
and by strip chart recorder at a paper speed of 50 mm/s along 
with the electrocardiogram and phonocardiogram. These 
were analyzed for chamber size and wall motion. 
Doppler echocardiographic studies were performed with 
a low cut filter to eliminate the influence of movement of 
intracardiac structures; cutoff frequency was 400 Hz for 
Doppler color flow studies and 1,600 Hz for continuous wave 
Doppler studies. For Doppler color flow studies, the pulse 
repetition frequency was set at 4 kHz, and multiple two- 
dimensional echocardiographic planes were imaged to obtain 
the maximal jet areas. Color gain was optimized as previ- 
ously described (8) by setting the gain at maximum just 
before the appearance of noise (gain 12). This was then kept 
constant for the examination. Depth setting was also kept 
constant and not adjusted further. Images were recorded on 
videotape for off-line analysis. 
Continuous wave Doppler studies were performed with a 
combined two-dimensional and Doppler 2.5 MHz duplex 
transducer. The direction of the continuous wave beam was 
adjusted as closely as possible to the regurgitant jet signal on 
the Doppler images using the parasternal and apical ap- 
proaches. Frequency analysis of continuous wave Doppler 
signals was carried out in real time by fast Fourier transfor- 
mation. Doppler signals were recorded by a strip chart 
recorder as described. 
Atrioventricular valve regurgitation was considered to be 
present if blue, green or mosaic signals were seen originating 
from the AV valve and spreading into the atrium during 
systole. Semilunar valve regurgitation was considered to be 
present if red, yellow or mosaic signals were seen to origi- 
nate from the semilunar valve and spread into the ventricle 
during diastole. 
Data analysis. Videotapes were analyzed on a frame by 
frame basis to compute the maximal area of the regurgitant 
jet signals in each plane. The maximal regurgitant jet area 
was measured by computerized planimetry as previously 
described (9). The maximal regurgitant jet area in each of 
several different planes was measured and the average of 
these used to quantify the regurgitation. The average maxi- 
mal jet area was expressed as a percent of the atria1 area 
obtained in the same plane as the maximal regurgitant jet. 
Statistical analysis. Statistical analysis of comparisons 
between patients and control subjects was performed using 
Student’s t test and the Mann-Whitney U test. Chi-square 
testing was used to analyze the difference in frequencies of 
regurgitation between the two groups. Linear regression 
analysis (least squares method) was used for correlations 
with continuous variables, and Spearman’s rank correlation 
was used for discrete variables. A value of p = 0.01 was 
considered significant. 
Results 
Two-dimensional and M-mode echocardiography. Two- 
dimensional and M-mode echocardiograms showed normal 
contraction of the left ventricle and normal valve motion in 
patients and control subjects. There was no significant 
difference in left atria1 size measured by M-mode echocar- 
diography between the two groups; it measured 29 * 5 mm 
578 AKASAKA ET AL. 
VALVULAR REGURGITATION AFTER TRANSPLANTATION 
JACC Vol. 15, No. 3 
March 1, 1!90:576-81 
(range 18 to 40) in patients and 30 ? 3 mm (range 20 to 38) in 
normal subjects (Table 1). Maximal atria1 area measured by 
planimetry was not significantly different between transplant 
patients and normal subjects (left atrium 1,054 ? 238 versus 
1,037 * 266 mm2; right atrium 1,145 ? 361 versus 1,093 ? 
254 mm2, respectively). There was no significant difference 
in left ventricular end-diastolic dimension or percent frac- 
tional shortening between the two groups. Left ventricular 
end-diastolic dimension was 43 -C 5 mm in patients and 43 + 
4 mm in control subjects. Fractional shortening was 32 + 7% 
in patients and 38 ? 6% in control subjects. 
Frequency of atrioventricular valve regurgitation. The 
frequency of mitral and tricuspid regurgitation was 52% and 
78%, respectively, in transplant patients. When present, 
mitral regurgitation was usually through the posteromedial 
portion of the valve. The frequency of mitral and tricuspid 
regurgitation in normal subjects was 42% and 68%, respec- 
tively. 
In 33 of 38 the transplant recipients with tricuspid regur- 
gitation, the pressure gradient between the right atrium and 
right ventricle could be estimated by continuous wave 
Doppler echocardiography using the simplified Bernoulli 
equation, and ranged from 14 to 32 (mean 19 ? 4) compared 
with 18 t 4 mm Hg in normal subjects. 
Although the frequency of AV valve regurgitation in 
transplant recipients was higher than in control subjects, this 
was not statistically significant (chi-square analysis, mitral 
regurgitation p = 0.15; tricuspid regurgitation p = 0.13). 
Severity of atrioventricular valve regurgitation. Severity 
of regurgitation was assessed using the average maximal 
regurgitant jet area assessed from multiple planes. This was 
significantly larger (p < 0.01) for both tricuspid and mitral 
valves in transplant recipients (156 t 120 and 84 ? 52 mm2, 
respectively) compared with values in normal subjects (40 -+ 
38 and 28 ~fr 26 mm2, respectively) (Fig. 1). When the 
average maximal regurgitant area was expressed as percent 
atria1 size, the values for transplant recipients were greater 
than for normal subjects for both mitral and tricuspid regur- 
gitation (p < 0.05 and p < 0.01, respectively [Wilcoxon 
rank]). Using linear regression analysis, the severity of AV 
regurgitation was not significantly correlated with patient or 
donor age, total donor organ ischemic time, time since 
operation or the number of previous rejection episodes. 
Patients receiving steroid immunosuppressive therapy for 
23 months were compared with the remaining patients and 
no significant difference was observed (Mann-Whitney U 
test, p = NS). 
Frequency and severity of semilunar valve regurgitation. 
Pulmonary regurgitation was commonly observed. In the 35 
transplant recipients in whom adequate views of the right 
ventricular outflow tract could be obtained, pulmonary re- 
gurgitation was demonstrated in 68%. Similarly pulmonary 
regurgitation could be demonstrated in 70% of the normal 
subjects. Regurgitant jet area was not significantly different 
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Figure 1. Maximal regurgitant jet area of mitral (MR), tricuspid 
(TR) and pulmonary regurgitation (PR) in normal subjects and 
heart-lung transplant recipients. Maximal regurgitant jet area of 
mitral and tricuspid regurgitation in transplant recipients (84 k 52 
and 156 2 120 mm’, respectively) was significantly larger than in 
normal subjects (28 I 26 and 40 * 38 mm’, respectively) (Student’s 
f test, p < 0.01). However, there is no significant difference in 
pulmonary regurgitant jet area between the two groups (32 k 26 
versus 28 k 26 mm*, p = NS). 
between patients and normal subjects (32 + 26 versus 28 + 
26 mm2) (Fig. 1). 
By comparison, aortic regurgitation was an uncommon 
finding in either group, with a frequency of 4% in patients 
and 2% in normal subjects. Neither frequency nor severity of 
pulmonary regurgitation was significantly correlated with 
patient or donor age, total donor organ ischemic time, time 
since operation, number of rejection episodes or steroid 
immunosuppression. 
Discussion 
Doppler color flow echocardiography provides a sensitive 
tool for assessing the occurrence of valvular regurgitation. It 
has been shown that regurgitant jet signals can be detected 
from the atrioventricular (AV) and pulmonary valves in a 
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large proportion of normal subjects, and are significantly 
smaller in area than those seen in individuals with abnormal 
valvular regurgitation (10). The true incidence of “physio- 
logic” regurgitation remains uncertain, and is also deter- 
mined by the equipment used and the criteria defined (1 I). 
For these reasons, we compared our patients undergoing 
heart-lung transplantation with a normal control group. In 
addition, we paid particular attention to standardizing gain, 
pulse repetition frequency and filter settings in both normal 
subjects and heart-lung transplant recipients to minimize 
variation due to technical factors. The frequency of regur- 
gitant signals in the normal control subjects is similar to that 
reported previously (IO). 
Previous studies. This study has demonstrated a high 
frequency of AV and pulmonary regurgitation after heart and 
lung transplantation. Previous studies (l-3) have shown a 
high occurrence of AV valve regurgitation after orthotopic 
cardiac transplantation using pulsed and continuous wave 
Doppler methods. Cladellas et al. (1) detected tricuspid, 
mitral and pulmonary regurgitation in 100%. 75% and 25% of 
patients, respectively. in the immediate postoperative period 
using pulsed Doppler echocardiography. Similarly, Lewen et 
al. (2) detected tricuspid regurgitation in 90% of patients. 
Importantly, none of these studies used Doppler color flow 
mapping. Our study is the first to define the presence and 
frequency of valvular regurgitation after heart and lung 
transplantation and indicates that valvular regurgitation oc- 
curs with a relatively high frequency after this procedure. 
However, this frequency of valvular regurgitation is not 
significantly different from that in a normal control group. 
Doppler color flow echocardiography to quantitate valvular 
regurgitation. This procedure was used in our study to 
assess the degree of valvular regurgitation. The quantitation 
of valvular regurgitation remains a difficult clinical problem 
(12). In our study, variation due to technique and equipment 
variables was minimized by attention to standardization of 
clinical technique and Doppler settings. However. it is 
acknowledged that the accurate quantitation of valvular 
regurgitation by Doppler color flow methods has limitations. 
The currently used reference standard of invasive angiogra- 
phy also has many limitations. and at best remains semi- 
quantitative. In particular, the quantitation of right-sided 
valvular regurgitation remains unsatisfactory (13). Taking 
into account these reservations, mitral regurgitation as mea- 
sured by Doppler color flow echocardiography has been 
shown by several workers to correlate well with angio- 
graphic gradings (9.14). In particular. the measurement of 
maximal or average maximal regurgitant jet areas in at least 
three orthogonal planes, as in this study, correlates well with 
angiographic gradings in mitral regurgitation (9). 
We have demonstrated that the degree of mitral regurgi- 
tation in heart and lung transplant recipients as assessed by 
this method is significantly greater than that in normal 
subjects, the mean maximal regurgitant jet area being nearly 
four times greater than that in normal control subjects. 
However. with use of the correlation defined by Helmcke et 
al. (9). all patients would be graded as having grade 1 mitral 
regurgitation only. We suggest that the degree of tricuspid 
regurgitation in the study patients similarly is significantly 
greater than normal, but in most is of minor grade only. At 
present. no adequate diagnostic standard exists for quanti- 
fying tricuspid regurgitation, angiographic methods being 
limited by spurious catheter-induced regurgitation. Doppler 
techniques have added significantly to the assessment of the 
severity of this lesion, but still have limitations (15-1X). The 
confirmation of our findings with regard to the severity of 
tricuspid regurgitation must await the development of an 
adequate reference standard. 
Etiology of valvular regurgitation. The difference in max- 
imal jet area of AV regurgitation in the heart-lung transplant 
recipients compared with normal subjects suggests that 
regurgitation of these valves is related to transplantation. 
The cause of this is unclear. Previous workers (2) have 
shown a relation between high pulmonary artery pressures 
(~55 mm Hg) before orthoptic cardiac transplantation and 
tricuspid regurgitation after transplantation, although post- 
transplant pulmonary artery pressures were well below 55 
mm Hg. It was suggested that the initial transient exposure 
of the heart to an elevated pulmonary artery pressure might 
be enough to create annular dilation and functional tricuspid 
regurgitation in an otherwise normal valve. These workers 
(2) also suggested that increased pulmonary vascular resis- 
tance in the native recipient lung was contributory. After 
heart and lung transplantation. pulmonary vascular resis- 
tance and pulmonary artery pressures are known to be 
normal (4.5). 
In this study, a systolic pressure gradient between the 
right atrium and the right ventricle was measured in 33 of the 
38 patients with tricuspid regurgitation by continuous wave 
Doppler echocardiography, using the simplified Bernoulli 
equation. This gradient was used to estimate pulmonary 
artery pressure and was within the range obtained for normal 
subjects with one exception, confirming that pulmonary 
artery pressure at the time of the Doppler study was not 
significantly elevated. Distortion of atria1 geometry as a 
result of the surgical technique of orthotopic cardiac trans- 
plantation has been offered as an explanation for AV regur- 
gitation. Left atria1 geometry is normal after heart-lung 
transplantation, so mitral regurgitation cannot be explained 
by distorted geometry in these patients. In our patients, both 
left atrial dimensions and geometry were within normal 
limits. However. both atria1 geometry and elevated pulmo- 
nary artery pressure and pulmonary resistance may be 
contributory factors in AV valve regurgitation in cardiac 
transplantation. This may account for the higher frequency 
of this lesion reported in cardiac transplantation by others 
(l-3) compared with the frequency in our study of patients 
with heart-lung transplantation. Similarly, the higher heart 
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rate seen in the denervated transplanted heart may influence 
the degree of regurgitation. In our study, it was not possible 
to use atropinized normal control subjects, so heart rate 
cannot be eliminated as a contributory factor. 
Infiltration of valve cusps by lymphoid tissue has been 
described after severe acute cardiac rejection (19), but this is 
otherwise an uncommon finding during rejection. We found 
no relation between the cumulative number of episodes of 
rejection and valvular regurgitation, and all valve cusps 
appeared to move normally and were not thickened. It would 
also be expected that the frequency of valvular regurgitation 
would be higher than normal and the degree of pulmonary 
regurgitation greater, which was not supported by this study. 
Role of papillary muscle dysfunction. Although left ven- 
tricular dimensions and contraction were normal in our 
patient group, we cannot exclude subtle degrees of left 
ventricular abnormality, in particular, dysfunction of the 
papillary muscles. It has been shown (10) that tricuspid 
regurgitation can be identified commonly in normal subjects 
and appears to represent true regurgitant flow. We have 
confirmed this finding in our normal study group and have 
shown a similar finding related to the mitral valve. We 
hypothesize that after heart-lung transplantation, a degree of 
papillary muscle dysfunction develops and that this allows 
greater regurgitant flow to occur through an otherwise 
normal AV valve. Papillary muscle dysfunction may occur 
on the basis of low grade rejection, undetectable with our 
current myocardial biopsy analysis techniques, because we 
have been unable to demonstrate a relation between the 
number of episodes of rejection and either tricuspid or mitral 
regurgitation. Minor myocardial damage may, therefore, be 
occurring during episodes of undetected low grade rejection. 
It is also possible that papillary muscle damage may have 
occurred during organ procurement because some investiga- 
tors (1) showed early but transient multivalvular regurgita- 
tion in orthotopic cardiac transplants. It would be expected 
that donor organ ischemic time would be related to valvular 
regurgitation, but we have not been able to demonstrate this. 
Further investigation will be needed to support the hypoth- 
esis of papillary muscle damage. 
Clinical significance. The clinical significance of AV 
valve regurgitation in these patients is more clearly defined. 
We observed that clinically significant tricuspid and mitral 
regurgitation is uncommon after either orthotopic cardiac or 
heart-lung transplantation at this institution (Harefield) in 
patients without current rejection. Routine left ventriculog- 
raphy is performed in all transplant recipients at the time of 
their yearly follow-up examination. More than 500 left 
ventriculograms have been performed in orthotopic cardiac 
transplant recipients up to 8 years after transplantation and 
>150 in heart-lung transplant recipients up to 3 years after 
transplantation. Mitral regurgitation regarded as clinically 
significant (rgrade 2) was observed in 7 of 502 orthotopic 
cardiac transplant recipients and did not occur more fre- 
quently with time. Similarly, significant mitral regurgitation 
appears to be uncommon after heart-lung transplantation 
(Mitchell AG, personal communication). Right ventriculog- 
raphy is not routinely performed at the time of annual 
follow-up study. 
Conclusions. Using Doppler color flow echocardiog- 
raphy, we demonstrated that AV valve regurgitation is 
common after heart-lung transplantation, but not signifi- 
cantly more common than in a normal control group. Its 
degree, as assessed by maximal regurgitant jet area, is 
significantly greater than in normal subjects. We postulate 
that AV valve regurgitation in heart-lung transplant recipi- 
ents may be due to low grade undetected rejection resulting 
in papillary muscle dysfunction. Clinically, AV valve regur- 
gitation does not seem to be a significant problem and does 
not appear to be progressive. 
We thank Toshiba Medical Company for providing the Toshiba SSH-65A 
echocardiography equipment, and Andrew Mitchell, MRCP and Derek Gib- 
son, MRCP for their constructive comments. 
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